002422.SZ
科伦药业
SZSE · Healthcare · C 制造业 · CN
CNY 41.44
−7.64%Year over year
Reported trailing growth
- Revenue
- -8.0%
- EBITDA
- —
- EBIT
- -41.9%
- EPS
- -37.4%
- Free cash flow
- -61.1%
- Operating cash flow
- -33.3%
Forward estimates
Based on analyst estimates
- Revenue
- +15.7%
- EBITDA
- +18.3%
- EPS
- +46.4%
Three-year CAGR
- Revenue
- -0.9%
- EBITDA
- +4.7%
- EBIT
- +4.7%
- Net income
- -0.1%
- EPS
- -4.3%
- Free cash flow
- -23.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026